Scott C Woller MD Profile
Scott C Woller MD

@SCWollerMD

Followers
225
Following
324
Media
12
Statuses
352

Physician, Intermountain Healthcare Professor of Medicine, University of Utah School of Medicine, Governor, UT Chapter ACP, Tweets my own.

Utah, USA
Joined November 2019
Don't wanna be here? Send us removal request.
@SCWollerMD
Scott C Woller MD
5 years
Grateful for the opportunity to collaborate at @Research_Inter with colleagues including @DrBenjaminHorne to understand how to best mitigate post-discharge thrombosis risk for hospitalized medical patients at featured in @CleClinicMD : https://t.co/FUiwcp6Jyu @Jess_Intermtn
1
0
7
@UT_ACP
Utah Chapter ACP
9 months
Congratulations to the @ACPIMPhysicians Utah Chapter Scientific Meeting for another amazing Scientific Meeting. Dr. Charlene Dewey, MD MACP from @VUMChealth provides a stellar keynote speech. @UofUInternalMed so well represented along with @Intermountain physician educators!
0
1
8
@UT_ACP
Utah Chapter ACP
9 months
Tremendous poster competition with @UofUInternalMed housestaff and students so well represented! @ACPIMPhysicians.
0
1
6
@DrBenjaminHorne
Benjamin Horne 🇺🇸
1 year
Methods of a cluster-randomized, type II hybrid implementation effectiveness trial to prospectively assess extended-duration thromboprophylaxis for at-risk medical patients being discharged to prevent venous thromboembolism @SCWollerMD @RPTHjournal
Tweet card summary image
rpthjournal.org
Venous thromboembolism (VTE) is the third leading cause of preventable hospital-associated (HA) death. Most HA-VTE, including fatal pulmonary emboli, occur among medically ill patients. The rate of...
1
3
2
@LanaCastellucci
Lana Castellucci
1 year
If you are looking for great resources and handouts to share the colleagues, patients, their families, check out @thrombosisday @ThrombosisCan @AnticoagForum @NATFthrombosis @ThrombosisUK @ThrombosisIrL and many, many others!
0
10
22
@isth
ISTH
1 year
We have over 180 registrants so far! Help us reach 200 by the end of the day to spread awareness for #WTDay24!
@thrombosisday
World Thrombosis Day
1 year
📣Register now for early access on Sept 24 to join the WTD Global Roundtable. All pre-registered participants will receive exclusive benefits, including: 📌Early access to the event recording 📌An exclusive handbook on women and thrombosis for healthcare professionals This
0
8
16
@UT_ACP
Utah Chapter ACP
1 year
Thank you to the @CDCDirector for sharing key health initiatives with us this morning at the @IMMattersACP Board of Governors meeting!
0
1
1
@UofUInternalMed
University of Utah Department of Internal Medicine
2 years
Congratulations to @AmikoUchidaMD and mentor Kathryn Peterson, MD, MSCI, for their recent study published in @JAMANetwork on eosinophilic gastrointestinal diseases. Explore their findings here: https://t.co/36yMoiHM7c #uofuhealth #internalmedicine #gastroenterology
1
4
16
@UT_ACP
Utah Chapter ACP
2 years
@Intermountain own Dr. Harris Carmichael presents physician attribution work @ACPIMPhysicians!
0
1
3
@RPTHjournal
RPTH
2 years
If you're interested in learning more we are holding an RPTH Research Recap on November 8. https://t.co/MXzw5s9L8n
0
2
6
@RPTHjournal
RPTH
2 years
Little is known of health-related quality of life (HRQoL) after venous thromboembolism (#VTE). @wang_huijie @MaryCushmanMD @Erik_Klok_MD @FritsRosendaal @Astridvhv report on change in HRQoL over 1 year after VTE in patients aged ���70 years. Read here 👇 https://t.co/pI4J2C6auy
0
8
14
@GBarnesMD
Geoff Barnes
2 years
What is the risk of #VTE recurrence for patients presenting with distal #DVT? It’s low, but meaningful over 5-10 years. Strength of index provoking risk factor was a strong predictor of recurrence. approx 2/3red we’re proximal DVT or PE. #ISTH2023
3
10
56
@Vasculearn
Vasculearn Network
2 years
🚨Paul Dobesh presenting some compelling data for use of Andexanet Alpha at #ISTH2023 Retrospective review comparing 4F-PCC (mean dose 2510units) to Andexanet (~2/3 low dose) 🌟Use if Andexanet Alpha led to a 50% decrease in in-house mortality. (1/3)
3
4
22
@AAllenPharmD
Arthur Allen
3 years
This was a great one! If you missed it check it out on @AnticoagForum website or the new YouTube
0
3
8
@sarahgcandler
Sarah Candler
3 years
What was that? Chairs of the Councils of Early Career Physicians, Resident/Fellow Members, and Student Members are all women? Mmmhmmmm that’s what I’m talking about!! @ACPIMPhysicians #IMProud #IM2023
2
10
68
@sarahgcandler
Sarah Candler
3 years
“Our diversity is our strength” @RyanMire1 on the benefits of Internal Medicine Physicians being “everywhere. From the exam room to the board room.” @ACPIMPhysicians #IMProud #IM2023
0
2
8
@AnticoagPharmD
Tara Lech PharmD, CACP
3 years
@AnticoagForum @NATFthrombosis @thrombosisday @isth @ThrombosisIrL @ThrombosisCan @ThrombosisUK @THSNA_Societies Let's help @SCWollerMD get some answers! Click on the link below and take a few minutes to fill out this brief survey
@SCWollerMD
Scott C Woller MD
3 years
Dear @AnticoagForum friends:   Can you help our ISTH SSC better understand how YOU think about DOAC use for DVT treatment in the elderly?   Will you please take our survey?   https://t.co/upHfT3uLx8
0
5
3
@AnticoagPharmD
Tara Lech PharmD, CACP
3 years
@SCWollerMD @AnticoagForum Are you able to add an option for Pharmacist with CDTM privileges?
2
1
1
@SCWollerMD
Scott C Woller MD
3 years
Congratulations to all board members @jean!
0
0
4